New York’s financial services watchdog is accepting public comments through Feb. 16 on proposed pharmacy benefit manager regulations that are intended to strengthen consumer protections and address anti-competitive conduct.

The proposed set of rules follows New York’s enactment of a 2021 law that is aimed at rooting out the former common practice of spread-pricing, which enables PBMs to charge pharmacists higher prices than they pay to manufacturers, yielding additional unknown profits.